PRICE研究:常规与扩散加权磁共振成像在评估接受放化疗后根治性手术的局部晚期宫颈癌患者中的作用
研究纳入88例局部晚期宫颈癌患者,在放化疗前(基线MRI)和放化疗2周后(早期MRI)测量肿瘤体积和ADCmean,按病理将治疗反应分为完全缓解(CR,40例)和部分缓解(PR,48例)。早期MRI肿瘤体积在PR组高于CR组(p=0.001),ΔTV下降在PR组低于CR组(63.6% vs 81.1%;p=0.001);ADCmean在两组间无差异。预测病理PR的最佳ΔTV下降截断值为73%,敏感度73%、特异度72.5%、准确率72.7%、NPV 76%、PPV 69%。
要点
- 早期MRI肿瘤体积可预测局部晚期宫颈癌对新辅助放化疗的病理反应。
- 预测病理部分缓解的最佳ΔTV下降截断值为73%。
- 早期MRI ADCmean测量与治疗结果不相关。
核心结论
- 治疗前及治疗早期评估的肿瘤体积可预测局部晚期宫颈癌的病理反应,而ADCmean与治疗结果不相关。
研究设计与样本
- 研究于2010年10月至2014年6月筛查108例组织学证实的宫颈癌女性,最终纳入88例;在基线MRI和放化疗2周后早期MRI测量肿瘤体积和ADCmean,以组织病理学为参考标准将治疗反应分为完全缓解(CR)和部分缓解(PR)。
关键影像表现/征象
- 基线MRI时肿瘤体积在CR组与PR组间无差异。
- 早期MRI时肿瘤体积PR组高于CR组(p=0.001)。
- 治疗后ΔTV下降PR组低于CR组(63.6% vs 81.1%;p=0.001)。
- 基线MRI和早期MRI的ADCmean在PR组与CR组间均无差异。
诊断标准与关键数值
- 预测病理PR的最佳ΔTV下降截断值为73%,敏感度73%、特异度72.5%、准确率72.7%、NPV 76%、PPV 69%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To analyse the role of DW-MRI in early prediction of pathologically-assessed residual disease in locally-advanced cervical cancer (LACC) treated with neoadjuvant chemoradiotherapy followed by radical surgery.
METHODS: Between October 2010-June 2014, 108 women with histologically-proven cervical cancer were screened; 88 were included in this study. Tumour volume (TV) and ADCmean were measured before (baseline-MRI) and after 2 weeks of chemoradiotherapy (early-MRI). According to histopathology, treatment response was classified as complete (CR) or partial (PR). Comparisons were made with Mann-Whitney, Wilcoxon and χ2 tests. ROC curves were generated for statistically significant parameters on univariate analysis.
RESULTS: CR and PR were documented in 40 and 48 patients. At baseline-MRI, TV did not differ between groups. At early-MRI, TV was higher in PR than in CR (p=0.001). ΔTV reduction after treatment was lower in PR than in CR (63.6% vs. 81.1%; p=0.001). At baseline-MRI and early-MRI, ADCmean did not differ between PR and CR. ROC curve showed best cut-off for predicting pathological PR was ΔTV reduction of 73% with sensitivity, specificity, accuracy, NPV, PPV of 73%, 72.5%, 72.7%, 76%, 69%.
CONCLUSIONS: TV evaluated before and early after treatment could predict pathological response in LACC. ADCmean did not correlate with treatment outcome.
KEY POINTS: • Early-MRI tumour volume assessment could predict pathological response to nCRT in LACC. • Best cut-off for predicting pathological PR was ΔTV reduction of 73 %. • Early-MRI ADC mean measurements did not correlate with treatment outcome.
引用
- Valentini AL, Miccò M, Gui B, et al. The PRICE study: The role of conventional and diffusion-weighted magnetic resonance imaging in assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. Eur Radiol. 2018. PMID: 29318432. doi:10.1007/s00330-017-5233-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。